Ultrasound for Fatty Liver Disease in Children
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores new ultrasound techniques to evaluate liver disease in children without invasive methods. Researchers aim to compare these advanced techniques with traditional methods like MRI scans and adapt them for portable ultrasound devices. Children aged 9 to 18 with risk factors for MASLD (a type of liver disease related to fat buildup) may qualify for this study. Participants must complete all study procedures and have no other liver conditions. As an unphased study, this trial offers participants the chance to contribute to innovative research that could lead to less invasive diagnostic options for liver disease in children.
Why are researchers excited about this trial?
Researchers are excited about using quantitative ultrasound to assess steatotic liver disease in children because it offers a non-invasive and radiation-free method to evaluate liver fat. Unlike traditional methods like liver biopsies, which are invasive and can be painful, this ultrasound technique is safe and comfortable for young patients. Additionally, it provides real-time results, making it easier for doctors to monitor liver health and potentially catch problems earlier. This approach could revolutionize how pediatric liver disease is diagnosed and managed, making it less stressful for both kids and their families.
Who Is on the Research Team?
Jeffrey B Schwimmer, MD
Principal Investigator
University of California, San Diego
Claude B Sirlin, MD
Principal Investigator
University of California, San Diego
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Ultrasound Evaluation
Participants undergo ultrasound exams using full-size or POCUS devices to develop and test QUS models
Follow-up
Participants are monitored for safety and effectiveness after ultrasound evaluation
What Are the Treatments Tested in This Trial?
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
This is a single arm study in which all participants undergo the same research procedures.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Diego
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator
GE Healthcare
Industry Sponsor
Fotis Vlachos
GE Healthcare
Chief Marketing Officer since 2024
PhD in Molecular Biology and Biochemistry from the University of Massachusetts, MBA from the Wharton School of the University of Pennsylvania
Peter J. Arduini
GE Healthcare
Chief Executive Officer since 2022
MBA from Northwestern University, BSc in Marketing from Susquehanna University
Virginia Polytechnic Institute and State University
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.